You are here
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
About this Study
RATIONALE: Prinomastat may stop the growth of glioblastoma multiforme by stopping blood flow
to the tumor. Drugs used in chemotherapy stop tumor cells from dividing so they stop growing
PURPOSE: Randomized phase II trial to study the effectiveness of prinomastat plus
temozolomide in treating patients who have newly diagnosed glioblastoma multiforme.